We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use °Ç¸ç³Ô¹Ï, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
VMD response to concerns raised following media reports of serious adverse events in cats administered Solensia.
Senior Scientific Officers, working on the authorisation in the UK of biological/immunological veterinary products.
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines in the UK.
This UK VARSS report provides the details of UK veterinary antibiotic resistance and sales surveillance.
This is the Hub for all the Veterinary Medicines Directorate's communications on current and future regulatory changes.
How to report suspected illegal activity and how we will deal with these reports.
Freedom of Information/Environmental Information Regulation requests for May 2026.
Summary of product characteristics for Syvazul BTV-3 vaccine in the UK
First published during the 2024 to 2026 Starmer Labour government
Guidance for the veterinary pharmaceutical industry on applying for maximum residue limits (MRLs) in the UK.
Apply for an authorisation to manufacture extemporaneous preparations, autogenous vaccines, stem cell products or blood products for non-food animals.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve °Ç¸ç³Ô¹Ï, we’d like to know more about your visit today. .